Carlos Marinas-Chillon
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Interaction of Signaling Lymphocytic Activation Molecule Family 1 (SLAMF1) receptor with Trypanosoma cruzi is strain-dependent and affects NADPH oxidase expression and activity.
Journal: PLoS neglected tropical diseases
Published: April 27, 2020
L-arginine supplementation reduces mortality and improves disease outcome in mice infected with Trypanosoma cruzi.
Journal: PLoS neglected tropical diseases
Published: August 28, 2017
A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses.
Journal: Scientific reports
Published: April 03, 2017
Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia.
Journal: PloS one
Published: July 12, 2016
Altered bone marrow lymphopoiesis and interleukin-6-dependent inhibition of thymocyte differentiation contribute to thymic atrophy during Trypanosoma cruzi infection.
Journal: Oncotarget
Published: March 17, 2016
Correction: Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.
Journal: PLoS neglected tropical diseases
Published: October 21, 2015
Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.
Journal: PLoS neglected tropical diseases
Published: March 10, 2015
Global metabolomic profiling of acute myocarditis caused by Trypanosoma cruzi infection.
Journal: PLoS neglected tropical diseases
Published: July 25, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026